Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world | Zendy

Massimo Tempestilli | Zendy; Gabriele Fabbri | Zendy; Ilaria Mastrorosa | Zendy; Laura Timelli | Zendy; Stefania Notari | Zendy; Rita Bellagamba | Zendy; Raffaella Libertone | Zendy; Federico Lupi | Zendy; Mauro Zaccarelli | Zendy; Andrea Antinori | Zendy; Chiara Agrati | Zendy; Adriana Ammassari | Zendy

Open Access

Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world

Author(s) -

Massimo Tempestilli,

Gabriele Fabbri,

Ilaria Mastrorosa,

Laura Timelli,

Stefania Notari,

Rita Bellagamba,

Raffaella Libertone,

Federico Lupi,

Mauro Zaccarelli,

Andrea Antinori,

Chiara Agrati,

Adriana Ammassari

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx348

Subject(s) - sofosbuvir , medicine , darunavir , ritonavir , raltegravir , dasabuvir , ombitasvir , daclatasvir , ledipasvir , paritaprevir , atazanavir , gastroenterology , pharmacology , viral load , hepatitis c virus , virology , human immunodeficiency virus (hiv) , antiretroviral therapy , virus , ribavirin

Possible drug-drug interactions (DDIs) between antiretrovirals (ARVs) and direct-acting antiviral agents (DAAs) are of some concern.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research